Page last updated: 2024-11-02

oxidopamine and Amnesia

oxidopamine has been researched along with Amnesia in 1 studies

Oxidopamine: A neurotransmitter analogue that depletes noradrenergic stores in nerve endings and induces a reduction of dopamine levels in the brain. Its mechanism of action is related to the production of cytolytic free-radicals.
oxidopamine : A benzenetriol that is phenethylamine in which the hydrogens at positions 2, 4, and 5 on the phenyl ring are replaced by hydroxy groups. It occurs naturally in human urine, but is also produced as a metabolite of the drug DOPA (used for the treatment of Parkinson's disease).

Amnesia: Pathologic partial or complete loss of the ability to recall past experiences (AMNESIA, RETROGRADE) or to form new memories (AMNESIA, ANTEROGRADE). This condition may be of organic or psychologic origin. Organic forms of amnesia are usually associated with dysfunction of the DIENCEPHALON or HIPPOCAMPUS. (From Adams et al., Principles of Neurology, 6th ed, pp426-7)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Genkova-Papazova, MG1
Stancheva, SL1
Alova, LG1
Lazarova-Bakarova, MB1

Other Studies

1 other study available for oxidopamine and Amnesia

ArticleYear
Adafenoxate abolishes the amnesia induced by neonatal 6-hydroxydopamine treatment in rats.
    Methods and findings in experimental and clinical pharmacology, 1993, Volume: 15, Issue:5

    Topics: Amnesia; Animals; Animals, Newborn; Avoidance Learning; Biogenic Amines; Brain; Cognition; Male; Mec

1993